市場調查報告書
商品編碼
1370270
除顫器市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Defibrillators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球除顫器市場規模達到51億美元。展望未來,IMARC Group預計到2028年市場規模將達到74億美元,2023-2028年年複合成長率(CAGR)為6.6%。
除顫器是指在危及生命的情況下(例如心室顫動、心律不整和無脈性室性心動過速)向患者心臟提供治療性電擊的醫療設備。它透過向心臟發送電脈衝或衝擊波來幫助恢復正常心跳。一些常見類型的去顫器包括自動體外去顫器(AED)、手動/穿戴式式體外除顫器、植入式心律轉復除顫器(ICD) 和經靜脈或皮下植入式心律轉復除顫器。這些設備主要用於醫院、診所、心臟中心、家庭護理機構和院前護理機構。
全球心血管疾病(CVD)和心臟驟停(SCA)盛行率的不斷上升是推動市場成長的關鍵因素之一。此類疾病在老年族群和患有糖尿病、動脈粥狀硬化、高血壓和中風等其他相關疾病的個體中非常普遍,這促進了已開發國家和新興國家對產品的採用。此外,醫療中心廣泛採用 ICD 也推動了市場成長。現代 ICD 與創新的皮下和經靜脈貼片整合,有助於提高患者的整體效率和舒適度。此外,各種技術進步和穿戴式心律轉復除顫器 (WCD) 的開發有助於預測 SCA 風險,也對市場成長產生正面影響。其他因素,包括實施促進除顫器培訓和認知的優惠政策,以及廣泛的研發(R&D)活動和增加政府對醫療保健行業的投資,預計將進一步推動市場。
The global defibrillators market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
A defibrillator refers to a medical device that delivers a therapeutic shock to the patient's heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia and pulseless ventricular tachycardia. It aids in restoring a normal heartbeat by sending electric pulses or shockwaves to the heart. Some of the common types of defibrillators include automated external defibrillators (AED), manual/wearable external defibrillators, implantable cardioverter defibrillators (ICDs) and transvenous or subcutaneous implantable cardioverter defibrillators. These devices are primarily used in hospitals, clinics, cardiac centers, home care settings and prehospital care settings.
The increasing prevalence of cardiovascular diseases (CVDs) and sudden cardiac arrest (SCA) across the globe is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other related ailments, such as diabetes, atherosclerosis, hypertension and stroke, which is facilitating the product adoption across both the developed and emerging nations. Furthermore, widespread adoption of ICDs across healthcare centers is also providing a boost to the market growth. Modern ICDs are integrated with innovative subcutaneous and transvenous patches that aid in improving the overall efficiency and level of comfort for the patient. Additionally, various technological advancements and the development of wearable cardioverter defibrillators (WCDs) that can aid in predicting the risks of SCAs, are also creating a positive impact on the market growth. Other factors, including the implementation of favorable policies to promote training and awareness regarding defibrillators, along with extensive research and development (R&D) activities and increasing government investments in the healthcare sector, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global defibrillators market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.
Implantable Defibrillators
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
External Defibrillators
Manual External Defibrillator
Automated External Defibrillator (AEDs)
Wearable Cardioverter Defibrillator (WCDs)
Hospitals and Clinics
Prehospital Care Settings
Cardiac Centers
Homecare Settings
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation, etc.